
INDICATIONS
Minor traumatology
ACTIVE INGREDIENTS
REPARIL 1% + 5% gel 100 g of gel contains: Active ingredients: Escin 1 g Diethylamine salicylate 5 g REPARIL 2% + 5% gel 100 g of gel contains: Active ingredients: Escin 2 g Diethylamine salicylate 5 g Excipients with known effects Lavender oil and bitter orange flower oil with d-limonene, farinasol and linalool. For the full list of excipients see section 6.1
EXCIPIENTS
Lavender essence, bitter orange flower essence, carbomers, macrogol 6 glycerol caprylocaprate, disodium edetate, trometamol, isopropyl alcohol, purified water.
CONTRAINDICATIONS AND SIDE EFFECTS
Hypersensitivity to the active substances or to any of the excipients. REPARIL should not be used on open lesions (wounds), mucous membranes and skin areas treated with radiation.
DOSAGE
Adults and adolescents (12-18 years): Apply and spread a thin layer of REPARIL on the skin of the area to be treated 1 to 3 times a day. Apply the gel directly to the affected area. After each application, wash your hands thoroughly. Children under 12 years: The safety and effectiveness of REPARIL in children under 12 years of age have not been established. There is no data available.
CONSERVATION
This medicinal product does not require any special storage conditions
WARNINGS
There is no risk of addiction and dependence. Since it is a preparation for topical applications, its use must be exclusively external. The use, especially prolonged, of products for topical use can give rise to sensitization phenomena. This medicine contains lavender oil and bitter orange blossom oil with d-limonene, farfalle and linalool as fragrances. These substances can cause allergic reactions.
INTERACTIONS
No interactions with other medicinal products have been reported.
SIDE EFFECTS
In rare cases, hypersensitivity reactions such as redness, scaling and dehydration of the skin may appear. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
OVERDOSE
No cases of overdose have been reported.
PREGNANCY AND BREASTFEEDING
In case of pregnancy and breastfeeding, it is not recommended to use REPARIL unless under strict medical supervision. However, prolonged use (maximum 3 weeks) of the product on large skin areas during pregnancy and use on the breasts during breastfeeding should be avoided.
EFFECTS ON DRIVING ABILITY
REPARIL does not affect the ability to drive or use machines.








